PLSE
PLSE
NASDAQ · Health Care

Pulse Biosciences Inc

$21.75
-0.27 (-1.23%)
Financial Highlights (FY 2026)
Revenue
352.0K
Net Income
-73,090,672
Gross Margin
-54.0%
Profit Margin
-20,794.6%
Rev Growth
-20.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 352.0K 443.4K 720.89M 620.86M
Gross Profit -190,053 -239,451 461.24M 397.24M
Operating Income -77,367,655 -87,729,481 62.62M 49.27M
Net Income -73,090,672 -82,879,683 60.22M 48.91M
Gross Margin -54.0% -54.0% 64.0% 64.0%
Operating Margin -21,982.6% -19,784.3% 8.7% 7.9%
Profit Margin -20,794.6% -19,754.8% 8.4% 7.9%
Rev Growth -20.6% -20.6% -7.3% +13.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 308.01M 262.97M
Total Equity 738.41M 772.91M
D/E Ratio 0.42 0.34
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -76,914,751 -92,061,249 74.89M 60.65M
Free Cash Flow 49.96M 50.83M